BDBM550549 8′-Methyl-6′-[(6-{[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 43

SMILES Cc1cc(Nc2ncnc3sc(C(=O)N4C[C@@H]5C[C@H]4CN5C)cc23)c(=O)n2c1C(=O)NC21CCCCC1

InChI Key InChIKey=DNCHAKVJQAAYPL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 550549   

TargetMAP kinase-interacting serine/threonine-protein kinase 1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 550549BDBM550549(8′-Methyl-6′-[(6-{[(1S,4S)-5-methyl-2,...)
Affinity DataIC50: 2.90nMAssay Description:MKNK1-inhibitory activity at high ATP of compounds of the present invention after their preincubation with MKNK1 was quantified employing the TR-FRET...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent